Symbicort 80 mikrograma/2,25 mikrograma po potisku, stlačeni inhalat, suspenzija
Name | Symbicort 80 mikrograma/2,25 mikrograma po potisku, stlačeni inhalat, suspenzija |
---|---|
Marketing Authorisation Number | HR-H-885448176 |
Active Substance | budezonid formoterolfumarat dihidrat |
Composition | Jedna isporučena doza (iz aktivatora) sadrži 80 mikrograma budezonida i 2,25 mikrograma formoterolfumarat dihidrata po potisku |
Pharmaceutical Form | stlačeni inhalat, suspenzija |
Manufacturer | AstraZeneca Dunkerque Production, Dunkerque, Francuska |
Marketing Authorisation Holder | AstraZeneca d.o.o., Ulica Vjekoslava Heinzela 70, Zagreb, Hrvatska |
Marketing Authorisation Date | 10.07.2020 |
MA Period of Validity | 10.07.2025 |
Classification Number | UP/I-530-09/19-01/99 |
Registration Number | 381-12-01/154-20-06 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | R03AK07 |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |